Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 8 studies | 32% ± 15% | |
neuron | 6 studies | 33% ± 11% | |
GABAergic neuron | 5 studies | 30% ± 11% | |
enteroendocrine cell | 5 studies | 50% ± 23% | |
pancreatic A cell | 4 studies | 90% ± 9% | |
type B pancreatic cell | 4 studies | 64% ± 22% | |
retinal ganglion cell | 4 studies | 67% ± 20% | |
neuroendocrine cell | 4 studies | 67% ± 16% | |
interneuron | 4 studies | 33% ± 17% | |
pancreatic D cell | 3 studies | 93% ± 2% | |
retinal bipolar neuron | 3 studies | 30% ± 12% | |
amacrine cell | 3 studies | 27% ± 12% | |
retina horizontal cell | 3 studies | 24% ± 9% | |
rod bipolar cell | 3 studies | 29% ± 10% | |
granule cell | 3 studies | 47% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 98% | 45980.67 | 254 / 258 | 98% | 18317.15 | 226 / 230 |
brain | 86% | 17360.73 | 2284 / 2642 | 91% | 87.73 | 639 / 705 |
pancreas | 88% | 3309.40 | 289 / 328 | 80% | 477.70 | 143 / 178 |
ovary | 59% | 2930.41 | 106 / 180 | 3% | 1.50 | 11 / 430 |
heart | 54% | 3256.79 | 463 / 861 | 0% | 0 | 0 / 0 |
thymus | 9% | 216.84 | 57 / 653 | 33% | 32.68 | 201 / 605 |
prostate | 10% | 218.31 | 25 / 245 | 26% | 8.97 | 130 / 502 |
kidney | 16% | 185.11 | 14 / 89 | 16% | 4.39 | 146 / 901 |
eye | 0% | 0 | 0 / 0 | 29% | 7.78 | 23 / 80 |
intestine | 13% | 149.12 | 121 / 966 | 11% | 18.06 | 58 / 527 |
stomach | 14% | 283.38 | 49 / 359 | 8% | 7.06 | 24 / 286 |
lung | 1% | 11.95 | 4 / 578 | 19% | 23.53 | 215 / 1155 |
muscle | 15% | 729.54 | 121 / 803 | 0% | 0 | 0 / 0 |
skin | 0% | 46.48 | 8 / 1809 | 11% | 3.41 | 51 / 472 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.84 | 3 / 29 |
tonsil | 0% | 0 | 0 / 0 | 9% | 135.25 | 4 / 45 |
bladder | 0% | 0 | 0 / 21 | 8% | 5.37 | 40 / 504 |
uterus | 1% | 9.82 | 2 / 170 | 6% | 3.04 | 29 / 459 |
breast | 1% | 18.10 | 3 / 459 | 6% | 80.16 | 72 / 1118 |
esophagus | 1% | 16.63 | 8 / 1445 | 5% | 3.48 | 9 / 183 |
liver | 0% | 11.73 | 1 / 226 | 4% | 1.72 | 18 / 406 |
blood vessel | 0% | 12.62 | 6 / 1335 | 0% | 0 | 0 / 0 |
spleen | 0% | 3.38 | 1 / 241 | 0% | 0 | 0 / 0 |
adipose | 0% | 16.86 | 3 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.94 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0005615 | Cellular component | extracellular space |
GO_0030141 | Cellular component | secretory granule |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005179 | Molecular function | hormone activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CHGB |
Protein name | Secretogranin-1 (Chromogranin-B) Secretogranin-1 (Chromogranin-B) (CgB) (Secretogranin I) (SgI) [Cleaved into: PE-11; GAWK peptide; CCB peptide] |
Synonyms | SCG1 |
Description | FUNCTION: Secretogranin-1 is a neuroendocrine secretory granule protein, which may be the precursor for other biologically active peptides. |
Accessions | ENST00000378961.9 ENST00000455042.1 A0A0A0MT66 P05060 |